Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
Jul 17, 2024
Contract Type
agreement
MiamiBiotechnologyHealth CareBiopharma
Description
OPKO Health has entered into a $250 million note purchase agreement with HealthCare Royalty, secured by OPKO’s profit share payments from Pfizer related to NGENLA™, a once-weekly treatment for pediatric growth hormone deficiency. This agreement allows OPKO to retain a significant portion of NGENLA's profit share payments in the near term, provides non-dilutive capital, and financial flexibility for research and development activities.
Company Information
Company
OPKO Health
Location
4400 Biscayne Blvd.
Miami, Florida, United States
About
OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and its novel and proprietary technologies. For more information, visit www.opko.com.